To further investigate the effects of METTL3 on VM formation in vivo, we established xenografts in nude mice and then injected METTL3-deleted and control HCT116 cells into the flanks of each mouse, and measured the tumor volume every 3 days after day 13. The gene discussed is METTL3; the disease is neoplasm.